Alibaba Health Information Technology Ltd

00241

Company Profile

  • Business description

    Alibaba Health is of one of China's leading e-commerce platform specializing in healthcare-related products, including prescription drugs, OTC drugs, traditional Chinese medicine, health foods, and so on. The company operates both a third-party B2C service, or 3P, and its own direct-to-consumer business, or 1P, with its own inventory, which can both be accessed by Alibaba’s Tmall app and Alipay. The company also provides online consultation services in a separate app called Yilu or “Dr. Deer,” although its e-commerce businesses remain its core competency in the long-term. E-commerce accounted for 93% of revenue in fiscal year 2022. We estimate that AliHealth holds about 45% of market share in the industry in terms of GMV. AliHealth is 63.74% owned by its parent company, Alibaba Group.

  • Contact

    Guanghua Road
    65th Floor, CITIC Tower, Building 1, No.10 Courtyard
    Jianwai Subdistrict, Chaoyang District
    Beijing
    CHN

    https://www.alihealth.cn

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Pharmaceutical Retailers

    Fiscal Year End

    31 March 2026

    Employees

    1,422

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,591.1019.700.23%
CAC 407,864.4446.05-0.58%
DAX 4023,999.17123.23-0.51%
Dow JONES (US)41,859.091.35-0.00%
FTSE 1008,739.2647.20-0.54%
HKSE23,679.99135.680.58%
NASDAQ18,925.7353.090.28%
Nikkei 22537,200.92215.050.58%
NZX 50 Index12,619.0143.24-0.34%
S&P 5005,842.012.60-0.04%
S&P/ASX 2008,366.1017.400.21%
SSE Composite Index3,382.962.770.08%

Market Movers